Purdue Pharmaceuticals, L.P.
One Stamford Forum
About Purdue Pharmaceuticals, L.P.
Purdue Pharmaceuticals, L.P., headquartered in Stamford, CT, is a privately held pharmaceutical company founded by physicians and focused on meeting the needs of healthcare providers and the patients in their care. Together with its independent associated companies, Purdue is dedicated to finding, developing, and bringing to market new medicines and related products that improve health outcomes. The company has long been known for its pioneering research on persistent pain, a principal cause of human suffering.
Purdue also has a growing line of non-prescription products including laxatives, microbicides, and nutraceuticals. The company is dedicated to serving the evolving needs of healthcare providers, patients, and caregivers with prescription and non-prescription medicines. A commitment to innovation and caring spans every aspect of the organization, from discovering and launching new medicines to demonstrating their medical value.
Purdue has led the battle against inadequate treatment of pain by developing sustained-release medications to manage pain. Its sales, marketing, and medical education professionals provide the healthcare community with comprehensive educational materials and programs relating to pain management.
In 1993, Purdue established Partners Against Pain® as a resource to help patients, caregivers, and healthcare professionals advance standards of pain care and alleviate unnecessary suffering through education and advocacy. Purdue has also assumed a leading role in addressing the serious public health problem of prescription drug abuse, supporting programs intended to help stem abuse.
At its research facilities in Cranbury, New Jersey, Purdue scientists are discovering new compounds to treat pain and developing formulations and delivery systems to help improve patient safety.
214 articles with Purdue Pharmaceuticals, L.P.
Purdue Pharma L.P. Release: New York State Court Denies Class Certification In OxyContin Litigation; No Classes Certified After Nearly Four Years Of Litigation
Purdue Pharma L.P. (Connecticut) Release: Ohio Supreme Court Denies Class Certification In OxyContin(R) Litigation
Norak Biosciences, Inc. Partners With Purdue Pharmaceuticals, L.P. For Access To Transfluor(R) Technology
Purdue Pharma L.P. (Connecticut) Selects Accellion's Enterprise E-Mail Attachment Caching Solution To Speed Large With Member Clinical Research Organizations
Elite Pharmaceuticals, Inc. Grants Purdue Pharma L.P. (Connecticut) Exclusive Right To Evaluate Its Abuse Resistance Drug Formulation Technology
Endo Pharmaceuticals Receives Final FDA Approval For Oxycodone Extended-Release Tablets; Shares Rise
Purdue Pharma L.P. (Connecticut) Files Notice Of Appeal In Endo Pharmaceuticals Patent Case; Commits To Expedited Process
Purdue Pharma L.P. Files Petition With FDA Requesting Risk Management Plans For All Generic Forms Of OxyContin
OxyContin Maker, Purdue Pharma L.P. (Connecticut), Used Deceit, Stalling Tactics To Block Generic Drugs And Gouge Consumers, According To Consumer Lawsuit